April 15, 2008
Vioxx and Medical Ghostwriters
The New York Times today reported on a JAMA article about medical ghostwriting, raising questions about the integrity of pharmaceutical research studies published in medical journals. Here's how the Times account begins:
The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigious doctors to put their names on the reports before publication, according to an article to be published Wednesday in a leading medical journal.
The article, based on documents unearthed in lawsuits over the pain drug Vioxx, provides a rare, detailed look in the industry practice of ghostwriting medical research studies that are then published in academic journals.
The article cited one draft of a Vioxx research study that was still in want of a big-name researcher, identifying the lead writer only as “External author?”
TrackBack URL for this entry:
Listed below are links to weblogs that reference Vioxx and Medical Ghostwriters:
» Ghostwriting of Medical Studies from TortsProf Blog
The New York Times examines the practice of ghost-writing medical research studies that are subsequently published in medical journals such as JAMA:The drug maker Merck drafted dozens of research studies for a best-selling drug, then lined up prestigio... [Read More]
Tracked on Apr 16, 2008 5:15:03 AM